
Matthew Bruner
South Dakota GOP activist and digital creator; Sergeant at Arms involved in 2024 state convention controversy
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Jul 24, 2026
Alopecia Areata Beyond the SALT Score: Patient Selection, Monitoring, and Long-Term Management
3:34
3:48
4:04
4:13
4:41
8:20

Jamie RestivoHOST
When a patient with alopecia areata presents in your office, what are some of the most important clinical and psychosocial factors you're evaluating during the first visit?

Matthew BrunerGUEST
So it's not only our job as clinicians to look at the physical findings for the patient, but also to recognize when a patient's quality of life impact and their distress misaligned with their physical hair loss or their SALT score.

Matthew BrunerGUEST
We should be determining disease severity and treatment urgency holistically, right? So to do this, we can think about our patients in a few different ways.

Matthew BrunerGUEST
uh so looking beyond that salt score so acknowledging that a patient who may have more limited or mild scalp involvement they can still experience a tremendous and disproportionate impact on their confidence their relationships and their overall quality of life So in doing that, we can better empathize with our patients and develop insights into what the patient's actually living with.

Matthew BrunerGUEST
As good clinicians, we want to look for the presence of anxiety and depression, social avoidance, withdrawal, their diminished self-confidence, or even suicidal thoughts that can all play into it.

Jamie RestivoHOST
So talking about patient selection, when you're thinking about a JAK inhibitor, what do you think are the appropriate candidates? Walk me through that a little bit.